Cargando…
Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in...
Autores principales: | Li, Mao, Wang, Zhanjun, Cui, Fang, Yang, Fei, Wang, Hongfen, Huang, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186325/ https://www.ncbi.nlm.nih.gov/pubmed/32373051 http://dx.doi.org/10.3389/fneur.2020.00277 |
Ejemplares similares
-
TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019) -
Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022) -
Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018) -
Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
por: Montagnese, Federica, et al.
Publicado: (2020) -
Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
por: Urata, Yuka, et al.
Publicado: (2020)